Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body. It is one of the most aggressive forms of skin cancer, with current ...
Abnormalities in tropomyosin receptor kinase can lead to cancer formation, and LOXO is targeting these as an anticancer strategy. Early clinical findings show great promise for its lead agent, ...
- First U.S. pivotal study for Alpha Tau to have completed enrollment, representing a critical milestone on the path towards potential FDA pre-market approval (PMA); Company has already initiated PMA ...
Medical Device Network on MSN
Alpha Tau concludes patient enrolment in ReSTART pivotal trial
The trial enrolled 88 patients with biopsy-confirmed recurrent cSCC unresponsive to first-line therapy.
Hosted on MSN
Alpha Tau to unveil early US brain cancer trial data
Key trial update: Alpha Tau will present interim data from its U.S. Regain study on recurrent glioblastoma, focusing on safety and feasibility. Novel treatment approach: Alpha DaRT implants radium-224 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results